Part 1 Industry Overview

1.1 Alzheimer’s Disease Drug Industry

1.1.1 Definition

1.1.2 Industry Trend

1.2 Industry Chain

1.2.1 Upstream

1.2.2 Technology

1.2.3 Cost Structure

1.2.4 Consumer Preference

1.2.2 Downstream

Part 2 Industry Overall

2.1 Industry History

2.2 Development Prospect

2.3 Competition Structure

2.4 Relevant Policy

2.5 Trade Overview

Part 3 Alzheimer’s Disease Drug Market by Product

3.1 Products List of Major Companies

3.2 Market Size

3.3 Market Forecast

4 Key Companies List

4.1 Lundbeck. (Company Overview, Sales Data etc.)

4.1.1 Company Overview

4.1.2 Products and Services

4.1.3 Business Analysis

4.2 Merz Pharma (Company Overview, Sales Data etc.)

4.2.1 Company Overview

4.2.2 Products and Services

4.2.3 Business Analysis

4.3 Eisai (Company Overview, Sales Data etc.)

4.3.1 Company Overview

4.3.2 Products and Services

4.3.3 Business Analysis

4.4 Daiichi Sankyo (Company Overview, Sales Data etc.)

4.4.1 Company Overview

4.4.2 Products and Services

4.4.3 Business Analysis

4.5 Novartis (Company Overview, Sales Data etc.)

4.5.1 Company Overview

4.5.2 Products and Services

4.5.3 Business Analysis

4.6 Novartis (Company Overview, Sales Data etc.)

4.6.1 Company Overview

4.6.2 Products and Services

4.6.3 Business Analysis

4.7 Allergan (Company Overview, Sales Data etc.)

4.7.1 Company Overview

4.7.2 Products and Services

4.7.3 Business Analysis

4.8 Pfizer (Company Overview, Sales Data etc.)

4.8.1 Company Overview

4.8.2 Products and Services

4.8.3 Business Analysis

Part 5 Market Competition

5.1 Companies Competition

5.2 Industry Competition Structure Analysis

5.2.1 Rivalry

5.2.2 Threat of New Entrants

5.2.3 Substitutes

5.2.4 Bargaining Power of Suppliers

5.2.5 Bargaining Power of Buyers

Part 6 Market Demand by Segment

6.1 Demand Situation

6.1.1 Industry Application Status

6.1.2 Industry SWOT Analysis

6.1.2.1 Strengths

6.1.2.2 Weaknesses

6.1.2.3 Opportunities

6.1.2.4 Threats

6.2 Major Customer Survey

6.3 Demand Forecast

Part 7 Region Operation

7.1 Regional Market

7.2 Production and Sales by Region

7.2.1 Production

7.2.2 Sales

7.2.3 Trade

7.3 Regional Forecast

Part 8 Market Investment

8.1 Market Features

8.1.1 Product Features

8.1.2 Price Features

8.1.3 Channel Features

8.1.4 Purchasing Features

8.2 Investment Opportunity

8.2.1 Regional Investment Opportunity

8.2.2 Industry Investment Opportunity

8.3 Investment Calculation

8.3.1 Cost Calculation

8.3.2 Revenue Calculation

8.3.3 Economic Performance Evaluation

Part 9 Conclusion

Table Global Alzheimer’s Disease Drug Market 2012-2017, by Type, in USD Million

Table Global Alzheimer’s Disease Drug Market 2012-2017, by Type, in Volume

Table Global Alzheimer’s Disease Drug Market Forecast 2018-2023, by Type, in USD Million

Table Global Alzheimer’s Disease Drug Market Forecast 2018-2023, by Type, in Volume

Table Lundbeck. Overview List

Table Alzheimer’s Disease Drug Business Operation of Lundbeck. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merz Pharma Overview List

Table Alzheimer’s Disease Drug Business Operation of Merz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eisai Overview List

Table Alzheimer’s Disease Drug Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table Alzheimer’s Disease Drug Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Alzheimer’s Disease Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Alzheimer’s Disease Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Allergan Overview List

Table Alzheimer’s Disease Drug Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Alzheimer’s Disease Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Alzheimer’s Disease Drug Sales Revenue 2012-2017, by Companies, in USD Million

Table Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies, in USD Million

Table Global Alzheimer’s Disease Drug Sales Volume 2012-2017, by Companies, in Volume

Table Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies in 2017, in Volume

Table Alzheimer’s Disease Drug Demand 2012-2017, by Application, in USD Million

Table Alzheimer’s Disease Drug Demand 2012-2017, by Application, in Volume

Table Alzheimer’s Disease Drug Demand Forecast 2018-2023, by Application, in USD Million

Table Alzheimer’s Disease Drug Demand Forecast 2018-2023, by Application, in Volume

Table Global Alzheimer’s Disease Drug Market 2012-2017, by Region, in USD Million

Table Global Alzheimer’s Disease Drug Market 2012-2017, by Region, in Volume

Table Alzheimer’s Disease Drug Market Forecast 2018-2023, by Region, in USD Million

Table Alzheimer’s Disease Drug Market Forecast 2018-2023, by Region, in Volume

Figure Alzheimer’s Disease Drug Industry Chain Structure

Figure Global Alzheimer’s Disease Drug Market Growth 2012-2017, by Type, in USD Million

Figure Global Alzheimer’s Disease Drug Market Growth 2012-2017, by Type, in Volume

Figure Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies in 2017, in USD Million

Figure Global Alzheimer’s Disease Drug Sales Volume Share 2012-2017, by Companies, in Volume

Figure Production Development by Region

Figure Sales List by Region